Ignite Creation Date:
2025-12-25 @ 2:03 AM
Ignite Modification Date:
2026-06-14 @ 9:03 AM
Study NCT ID:
NCT06021860
Status:
UNKNOWN
Last Update Posted:
2023-09-28
First Post:
2023-08-28
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase IV, Two-part, Open-label Study Assessing the Pharmacokinetics, Safety and Pharmacodynamics of Spironolactone Oral Suspension in Pediatric Patients
Sponsor:
CMP Development, LLC
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Edema Due to Heart Failure or Cirrhosis | View |
Keywords: